These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3122616)

  • 1. Marked disparity in incidence of bacterial infections in patients with the acquired immunodeficiency syndrome receiving interleukin-2 or interferon-gamma.
    Murphy PM; Lane HC; Gallin JI; Fauci AS
    Ann Intern Med; 1988 Jan; 108(1):36-41. PubMed ID: 3122616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-interferon therapy in patients with poor-prognosis Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). A phase II trial with preliminary evidence of antiviral activity and low incidence of opportunistic infections.
    Miles SA; Wang HJ; Cortes E; Carden J; Marcus S; Mitsuyasu RT
    Ann Intern Med; 1990 Apr; 112(8):582-9. PubMed ID: 2109563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infections associated with Hickman catheters in patients with acquired immunodeficiency syndrome.
    Raviglione MC; Battan R; Pablos-Mendez A; Aceves-Casillas P; Mullen MP; Taranta A
    Am J Med; 1989 Jun; 86(6 Pt 2):780-6. PubMed ID: 2729339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective combination therapy using interferon-gamma and interleukin-2 for disseminated Mycobacterium avium complex infection in a pediatric patient with AIDS.
    Sekiguchi Y; Yasui K; Yamazaki T; Agematsu K; Kobayashi N; Koike K
    Clin Infect Dis; 2005 Dec; 41(11):e104-6. PubMed ID: 16267723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma therapy in AIDS for mononuclear phagocyte activation.
    Murray HW
    Biotherapy; 1990; 2(2):149-58. PubMed ID: 2119203
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapy of acquired immune deficiency syndrome with recombinant interleukin-2.
    Volberding P; Moody DJ; Beardslee D; Bradley EC; Wofsy CB
    AIDS Res Hum Retroviruses; 1987; 3(2):115-24. PubMed ID: 3113462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating interferon gamma in AIDS patients treated with interleukin-2.
    Murray HW; DePamphilis J; Schooley RT; Hirsch MS
    N Engl J Med; 1988 Jun; 318(23):1538-9. PubMed ID: 3130575
    [No Abstract]   [Full Text] [Related]  

  • 8. Infectious complications associated with interleukin-2 administration: a retrospective review of 935 treatment courses.
    Pockaj BA; Topalian SL; Steinberg SM; White DE; Rosenberg SA
    J Clin Oncol; 1993 Jan; 11(1):136-47. PubMed ID: 8418224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nosocomial sepsis associated with interleukin-2.
    Snydman DR; Sullivan B; Gill M; Gould JA; Parkinson DR; Atkins MB
    Ann Intern Med; 1990 Jan; 112(2):102-7. PubMed ID: 2403767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community-acquired bacteremia in patients with acquired immunodeficiency syndrome: clinical presentation, bacteriology, and outcome.
    Krumholz HM; Sande MA; Lo B
    Am J Med; 1989 Jun; 86(6 Pt 2):776-9. PubMed ID: 2729338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic approaches to patients with AIDS.
    Lane HC; Masur H; Gelmann EP; Fauci AS
    Cancer Res; 1985 Sep; 45(9 Suppl):4674s-4676s. PubMed ID: 2990706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic reconstitution in the acquired immunodeficiency syndrome.
    Lane HC; Fauci AS
    Ann Intern Med; 1985 Nov; 103(5):714-8. PubMed ID: 2996405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS).
    Kovacs JA; Deyton L; Davey R; Falloon J; Zunich K; Lee D; Metcalf JA; Bigley JW; Sawyer LA; Zoon KC
    Ann Intern Med; 1989 Aug; 111(4):280-7. PubMed ID: 2757312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma cytokines, cytokine antagonists, and disease progression in African women infected with HIV-1.
    Thea DM; Porat R; Nagimbi K; Baangi M; St Louis ME; Kaplan G; Dinarello CA; Keusch GT
    Ann Intern Med; 1996 Apr; 124(8):757-62. PubMed ID: 8633837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial.
    Lane HC; Davey V; Kovacs JA; Feinberg J; Metcalf JA; Herpin B; Walker R; Deyton L; Davey RT; Falloon J
    Ann Intern Med; 1990 Jun; 112(11):805-11. PubMed ID: 1971503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No new ways of treating AIDS.
    Maddox J
    Nature; 1984 Mar 8-14; 308(5955):107. PubMed ID: 6422309
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of AIDS-related Kaposi's sarcoma with recombinant gamma-interferon.
    Ganser A; Brücher W; Brodt HR; Busch W; Brandhorst I; Helm EB; Hoelzer D
    Onkologie; 1986 Jun; 9(3):163-6. PubMed ID: 3018647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary clinical observations with recombinant interleukin-2 in patients with AIDS or LAS.
    Kern P; Toy J; Dietrich M
    Blut; 1985 Jan; 50(1):1-6. PubMed ID: 3871344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of interferon in the therapy of epidemic Kaposi's sarcoma.
    Krown SE
    Semin Oncol; 1987 Jun; 14(2 Suppl 3):27-33. PubMed ID: 2440110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of neutropenia in patients with human immunodeficiency virus infection.
    Farber BF; Lesser M; Kaplan MH; Woltmann J; Napolitano B; Armellino D
    Infect Control Hosp Epidemiol; 1991 Jul; 12(7):429-34. PubMed ID: 1918889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.